Citigroup
GCTK icon

Citigroup’s GlucoTrack GCTK Stock Holding History

Citigroup’s Portfolio GCTK Stock Details GCTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.11K Buy
+12,872
New +$8.07K ﹤0.01% 5331

Other funds holding GCTK

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
GIPW
Granite Islands Private Wealth Guilford, Connecticut $135M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AF
Alerus Financial Grand Forks, North Dakota $2.29B AUM 30.87% 1-Year Est. Return

Citigroup's GCTK Position: Q2 2026 in Review

Citigroup opened a new position in GlucoTrack (GCTK) in Q2 2026: 12,872 shares worth $4.11K. The stake represents ﹤0.01% of the portfolio and ranks #5331 among its holdings.

18 funds tracked by Wall St. Rank hold GCTK as of Q2 2026.

  • Citigroup held 12,872 shares of GlucoTrack worth $4.11K as of Q2 2026.
  • GlucoTrack was a new Citigroup position in Q2 2026.
  • GlucoTrack made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5331 holding.
  • 18 funds tracked by Wall St. Rank held GlucoTrack as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.